The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia
- PMID: 8054493
- DOI: 10.1017/s1041610294001602
The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia
Abstract
The Cognitive Abilities Screening Instrument (CASI) has a score range of 0 to 100 and provides quantitative assessment on attention, concentration, orientation, short-term memory, long-term memory, language abilities, visual construction, list-generating fluency, abstraction, and judgment. Scores of the Mini-Mental State Examination, the Modified Mini-Mental State Test, and the Hasegawa Dementia Screening Scale can also be estimated from subsets of the CASI items. Pilot testing conducted in Japan and in the United States has demonstrated its cross-cultural applicability and its usefulness in screening for dementia, in monitoring disease progression, and in providing profiles of cognitive impairment. Typical administration time is 15 to 20 minutes. Record form, manual, videotape of test administration, and quizzes to qualify potential users on the administration and scoring of the CASI are available upon request.
Similar articles
-
Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen.Psychol Med. 1994 Aug;24(3):763-70. doi: 10.1017/s0033291700027914. Psychol Med. 1994. PMID: 7991758
-
Japanese-English language equivalence of the Cognitive Abilities Screening Instrument among Japanese-Americans.Int Psychogeriatr. 2009 Feb;21(1):129-37. doi: 10.1017/S1041610208007862. Epub 2008 Oct 24. Int Psychogeriatr. 2009. PMID: 18947456 Free PMC article.
-
Evaluating the uses of the total score and the domain scores in the Cognitive Abilities Screening Instrument, Chinese version (CASI C-2.0): results of confirmatory factor analysis.Int Psychogeriatr. 2007 Dec;19(6):1051-63. doi: 10.1017/S1041610207005327. Epub 2007 Apr 23. Int Psychogeriatr. 2007. PMID: 17451615
-
Screening for dementia in primary care: a review of the use, efficacy and quality of measures.Int Psychogeriatr. 2008 Oct;20(5):911-26. doi: 10.1017/S1041610208007394. Epub 2008 Jun 5. Int Psychogeriatr. 2008. PMID: 18533066 Review.
-
Clock-drawing: is it the ideal cognitive screening test?Int J Geriatr Psychiatry. 2000 Jun;15(6):548-61. doi: 10.1002/1099-1166(200006)15:6<548::aid-gps242>3.0.co;2-u. Int J Geriatr Psychiatry. 2000. PMID: 10861923 Review.
Cited by
-
Long term outcomes of intracarotid arterial transfusion of circulatory-derived autologous CD34 + cells for acute ischemic stroke patients-A randomized, open-label, controlled phase II clinical trial.Stem Cell Res Ther. 2024 Nov 20;15(1):443. doi: 10.1186/s13287-024-04021-7. Stem Cell Res Ther. 2024. PMID: 39568005 Free PMC article. Clinical Trial.
-
A multi-objective optimal control approach to motor strategy changes in older people with mild cognitive impairment during obstacle crossing.J Neuroeng Rehabil. 2024 Nov 6;21(1):200. doi: 10.1186/s12984-024-01483-x. J Neuroeng Rehabil. 2024. PMID: 39506783 Free PMC article.
-
Exposing telomere length's impact on malnutrition risk among older adults residing in the community: Insights from cross-sectional data analysis.PLoS One. 2024 Nov 5;19(11):e0308612. doi: 10.1371/journal.pone.0308612. eCollection 2024. PLoS One. 2024. PMID: 39499700 Free PMC article.
-
Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From the ACT Autopsy Cohort.Neurology. 2024 Nov 26;103(10):e210009. doi: 10.1212/WNL.0000000000210009. Epub 2024 Oct 31. Neurology. 2024. PMID: 39481068
-
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x. Transl Neurodegener. 2024. PMID: 39232848 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical